$2.07
▼ -1.4% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment
MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Overview
52-week range
$1.79
$24
1% of range
Avg surprise (last 3)
-23.2%
Avg reaction (last 2)
+0.9%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-2.48 | $-1.69 | -46.8% | -259.4% | +2.8% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.49 | $-0.39 | -25.6% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.69 | $-0.71 | +2.8% | — | -0.9% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$1.53 | -$12.25 | +87.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | — | $0 | $0 | $0 | — | $0 | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-8M | — | $-6M | $-6M | $-6M | — | $-7M | $-6M |
| Net income | $-13M | — | $-25M | $-18M | $-6M | — | $-7M | $-6M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | $9M | $7M | $8M | $8M | $4M | $9M | $11M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $11M | $10M | $8M | $9M | $9M | $5M | $12M | $14M |
| Total assets | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $7M | $47M | $25M | $7M | $6M | $16M | $8M |
| Total equity | $15M | $15M | $-27M | $-4M | $14M | $11M | $17M | $19M |
Implied volatility — last 90 days
No IV snapshots yet for MBRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.